PP2A catalytic subunit alpha is critically required for CD8 + T‐cell homeostasis and antibacterial responses
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451080 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Xian Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Homeostasis, Protein Phosphatase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Although the functions of tyrosine phosphatases in T‐cell biology have been extensively studied, our knowledge on the contribution of serine/threonine phosphatases in T cells remains poor. Protein phosphatase 2A (PP2A) is one of the most abundantly expressed serine/threonine phosphatases. It is important in thymocyte development and CD4 + T‐cell differentiation. Utilizing a genetic model in which its catalytic subunit alpha isoform (PP2A Cα) is deleted in T cells, we investigated its contribution to CD8 + T‐cell homeostasis and effector functions. Our results demonstrate that T‐cell intrinsic PP2A Cα is critically required for CD8 + T‐cell homeostasis in secondary lymphoid organs and intestinal mucosal site. Importantly, PP2A Cα–deficient CD8 + T cells exhibit reduced proliferation and survival. CD8 + T‐cell antibacterial response is strictly dependent on PP2A Cα. Expression of Bcl2 transgene rescues CD8 + T‐cell homeostasis in spleens, but not in intestinal mucosal site, nor does it restore defective antibacterial responses. Finally, proteomics and phosphoproteomics analyses reveal potential targets dependent on PP2A Cα, including mTORC1 and AKT. Thus, PP2A Cα is a key modulator of CD8 + T‐cell homeostasis and effector functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
- Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Förderung
- NIAMS NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Zhou, X., Li, M., Ai, M., Li, Y., Zhu, X., Hansen, M. J., Zhong, J., Johnson, K. L., Zenka, R., Pandey, A., Pease, L. R., & Zeng, H. (2024). PP2A catalytic subunit alpha is critically required for CD8 + T‐cell homeostasis and antibacterial responses. European Journal of Immunology. https://doi.org/10.1002/eji.202451080
Vancouver
Zhou X, Li M, Ai M, Li Y, Zhu X, Hansen MJ, et al. PP2A catalytic subunit alpha is critically required for CD8 + T‐cell homeostasis and antibacterial responses. European Journal of Immunology. 2024. doi:10.1002/eji.202451080
BibTeX
@article{Zhou2024,
author = {Zhou, Xian and Li, Meilu and Ai, Minji and Li, Yanfeng and Zhu, Xingxing and Hansen, Michael J and Zhong, Jun and Johnson, Kenneth L and Zenka, Roman and Pandey, Akhilesh and Pease, Larry R and Zeng, Hu},
title = {PP2A catalytic subunit alpha is critically required for CD8 + T‐cell homeostasis and antibacterial responses},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451080}
}
EUVIMED